NIRS in traumatic intracranial hematoma detection in traumatic head injury

Timely identification and treatment of intracranial injuries in the elderly are vital to prevent rapid deterioration and improve outcomes. By potentially reducing diagnostic delays, CEREBO may offer substantial improvements in the standard care for elderly TBI patients, leading to better health outcomes and reduced healthcare burdens. This clinical study is designed to assess the performance of CEREBO, an intracranial injury detector, in the detection of traumatic intracranial injuries among individuals aged 65 years and older. The study will investigate the efficacy of CEREBO in a demographic with a higher risk of TBI complications. The results from CEREBO will be compared against head CT scans to determine accuracy and reliability in this specific age group. The primary aim is to improve the early detection of intracranial injuries. The study will also assess the efficacy of the NIRS device in continuous monitoring of TBI patients under conservative treatment. It will evaluate whether there exists a significant correlation between the NIRS data and the depth and volume of hematoma within the same subject.